<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01855269</url>
  </required_header>
  <id_info>
    <org_study_id>134/Feb 2012</org_study_id>
    <nct_id>NCT01855269</nct_id>
  </id_info>
  <brief_title>Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic: a Prospective Study</brief_title>
  <official_title>A Prospective Randomized Controlled Study: Lactobacillus Reuteri Versus Herbal Drop in the Treatment of Infantile Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Sami Ulus Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Sami Ulus Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim was to test the hypothesis that oral administration of Lactobacillus reuteri in a
      prospective randomized controlled study would improve symptoms of infantile colic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infantile colic ıs one of the most common problems within the first 3 months of life,
      affecting as many as 3% to 28% of newborn children. It consists of a behavioral syndrome
      characterized by paroxysmal, excessive, inconsolable crying without identifiable cause.
      Lactobacillus reuteri, one of the few endogenous lactobacillus species in the human
      gastrointestinal tract, has been used safely for many years as a probiotic dietary supplement
      in adults, and recent data demonstrated safety after long-term dietary supplementation for
      newborn infants. The positive effects of this probiotic on intestinal disorders such as
      constipation and diarrhea and in protection from infection,as well as its capacity to
      modulate immune responses.

      The aim was to test the hypothesis that oral administration of Lactobacillus reuteri in a
      prospective randomized controlled study would improve symptoms of infantile colic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Crying time</measure>
    <time_frame>3 weeks</time_frame>
    <description>Infants crying episodes, feeding and stooling characteristics, growth, weight gain were noted weekly for three weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postpartum depression</measure>
    <time_frame>3 weeks</time_frame>
    <description>Emotional structures of mother's behaviour were evaluated before and at 2nd month with Edinburgh postpartum depression scale (EPDS), State Trait Anxiety Inventory (STAI) tests.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Crying</condition>
  <arm_group>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus reuteri (BioGaia, Stockholm, Sweden):at a dose of 100 million colony forming unit in 5 drops, 30 minutes after feeding, once per day for 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Herbal drop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Herbal drop containing sodium bicarbonate, Pimpinella anisum oil, foeniculum vulgare oil, Mentha piperita (Babs, Berko, Istanbul, Turkey):5 drops 30 minutes after feeding, once per day for 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterile water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile water: 5 drops, 30 minutes after feeding, once per day for 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri</intervention_name>
    <description>Lactobacillus reuteri (BioGaia, Stockholm, Sweden):at a dose of 100 million colony forming unit in 5 drops, 30 minutes after feeding, once per day for 3 weeks</description>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <other_name>Biogaia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Herbal drop</intervention_name>
    <description>Herbal drop containing sodium bicarbonate, Pimpinella anisum oil,foeniculum vulgare oil, Mentha piperita (Babs, Berko, Istanbul, Turkey):5 drops 30 minutes after feeding, once per day for 3 weeks</description>
    <arm_group_label>Herbal drop</arm_group_label>
    <other_name>Babs</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo sterile water</intervention_name>
    <arm_group_label>Sterile water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infants three weeks to three months

          -  infants with colic three hours of crying on three days in the week

          -  infants feeding with breast milk

          -  infants weighing 2500 to 4000 gram

        Exclusion Criteria:

          -  chronic illness

          -  gastrointestinal disorders

          -  infants received either antibiotics or probiotics in the previous week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nilgün Karadağ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD, Sami Ulus CH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sami Ulus CH</name>
      <address>
        <city>Ankara</city>
        <zip>06120</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 Jan;119(1):e124-30.</citation>
    <PMID>17200238</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2013</study_first_submitted>
  <study_first_submitted_qc>May 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2013</study_first_posted>
  <last_update_submitted>May 15, 2013</last_update_submitted>
  <last_update_submitted_qc>May 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Sami Ulus Children's Hospital</investigator_affiliation>
    <investigator_full_name>Dilek Dilli</investigator_full_name>
    <investigator_title>Assoc Prof</investigator_title>
  </responsible_party>
  <keyword>probiotic</keyword>
  <keyword>infantile colic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

